Floatz logo

rg4733

Adult Solid Neoplasm

National Cancer Institute (NCI)Phase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Adult Solid Neoplasm cohort.

Asset / SponsorPhaseRating
Veliparib
National Cancer Institute (NCI)
Phase 1/2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Roswell Park Cancer Institute
Phase 1/2BB
Vinorelbine
National Cancer Institute (NCI)
Phase 1/2BB
azd6244
National Cancer Institute (NCI)
Phase 2BB
Cediranib
National Cancer Institute (NCI)
Phase 1/2B

View all 50 →

Same molecule, other indications

rg4733 is also rated in:

non-small cell lung carcinomaDormant
CCC
Indicative ·
51 / 100
View asset →
melanomaDormant
CCC
Indicative ·
51 / 100
View asset →
Stage IV Skin MelanomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →